Quick Takeaways
- Laura Brege has 4 issuer positions tracked on this page.
- Estimated disclosed ownership value: $2,732,622.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Laura Brege
- Location
- Emeryville, CA
- Summary
- The estimated net worth of Laura Brege is at least $2,732,622 dollars as of 12 Sep 2025. Laura Brege is the Director of Mirum Pharmaceuticals, Inc. and owns shares of Mirum Pharmaceuticals, Inc. (MIRM) stock worth about $1.33M. Laura Brege is the Director of Pacira BioSciences, Inc. and owns shares of Pacira BioSciences, Inc. (PCRX) stock worth about $919.6K. Laura Brege is the Director of ACADIA PHARMACEUTICALS INC and owns shares of ACADIA PHARMACEUTICALS INC (ACAD) stock worth about $487.8K.
- Signature
- /s/ Judit Ryvkin, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Laura Brege and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Mirum Pharmaceuticals, Inc. ($1,325,277).
- Past-year value change for that position: -$1,264,868.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Laura Brege
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| MIRM | Mirum Pharmaceuticals, Inc. | Director | $1,325,277 | -$1,264,868 | -49% | 11 Sep 2025 |
| PCRX | Pacira BioSciences, Inc. | Director | $919,560 | 11 Jun 2025 | ||
| ACAD | ACADIA PHARMACEUTICALS INC | Director | $487,785 | -$314,634 | -39% | 04 Jun 2025 |
| EWTX | Edgewise Therapeutics, Inc. | Director | 16 Jun 2025 |
Insider Transactions Reported by Laura Brege:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.